Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Transitional Cell

Explore clinical trials studying Carcinoma, Transitional Cell. Study availability and eligibility vary by location and protocol.

417 public trials 125 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Transitional Cell trial results

Completed

Brazilian Reality of Urinary Bladder Cancers - BRA-BLADDER

NCT05945108

Conditions
Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +16 more
Locations
  • Research Site Belo Horizonte, Brazil
  • Research Site Porto Alegre, Brazil
  • Research Site Recife, Brazil
  • Research Site Salvador, Brazil
View Trial Details
Completed

Phase 1b/2 Study of Rogaratinib (BAY1163877) in Combination With Atezolizumab in Urothelial Carcinoma

NCT03473756

Conditions
Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +13 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • UChicago Medicine Comprehensive Cancer Center - Hyde Park Chicago, Illinois, United States
  • Barbara Ann Karmanos Cancer Institute - Detroit Headquarters Detroit, Michigan, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
View all 30 locations
View Trial Details
Completed

A Study of BMS-986416 With and Without Nivolumab in Select Solid Tumors

NCT04943900

Conditions
Adenocarcinoma, Advanced Solid Tumors, Bronchial Neoplasms, +21 more
Locations
  • Local Institution - 0006 Atlanta, Georgia, United States
  • Local Institution - 0005 Baltimore, Maryland, United States
  • Local Institution - 0002 Hackensack, New Jersey, United States
  • Local Institution - 0013 Cleveland, Ohio, United States
View all 19 locations
View Trial Details
Completed

SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas

NCT03894618

Conditions
Adenocarcinoma, Anus Diseases, Anus Neoplasms, +68 more
Locations
  • The Sarah Cannon Research Institute Nashville, Tennessee, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • Leuven Cancer Institute Leuven, Belgium
  • Princess Margaret Cancer Center Toronto, Ontario, Canada
View Trial Details
Completed

A Study to Learn About the Study Medicine (Avelumab) in Japanese Patients With Urothelial Carcinoma That Has Spread

NCT05431777

Conditions
Carcinoma, Carcinoma, Transitional Cell, Neoplasms, +3 more
Locations
  • National Hospital Organization Nagoya Medical Center Nagoya, Aichi-ken, Japan
  • Asahi General Hospital Asahi, Chiba, Japan
  • Kurume University Hospital Kurume, Fukuoka, Japan
  • Ogaki Municipal Hospital Ōgaki, Gifu, Japan
View all 16 locations
View Trial Details
Completed

Neoadjuvant Pembrolizumab in Combination With Gemcitabine Therapy in Cis-eligible/Ineligible UC Subjects

NCT02365766

Conditions
Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +14 more
Locations
  • Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States
  • IU Health Central Indiana Cancer Center Indianapolis, Indiana, United States
  • Community Regional Cancer Care Indianapolis, Indiana, United States
  • St. Vincent Hospital Indianapolis, Indiana, United States
View Trial Details
Completed

A Study of E7130 in Participants With Solid Tumors

NCT03444701

Conditions
Carcinoma, Carcinoma, Squamous Cell, Carcinoma, Transitional Cell, +7 more
Locations
  • Eisai Trial Site 9 Nagoya, Aichi-ken, Japan
  • Eisai Trial Site 1 Kashiwa, Chiba, Japan
  • Eisai Trial Site 6 Kashiwa, Chiba, Japan
  • Eisai Trial Site 8 Sapporo, Hokkaido, Japan
View Trial Details

Related conditions